Median Technologies (ENXTPA:ALMDT) - Share price, News & Analysis

ALMDT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

ALMDT Stock Overview

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally.

Rewards

Revenue is forecast to grow 31.39% per year

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months

Shareholders have been diluted in the past year

Median Technologies Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Median Technologies
Historical stock prices
Current Share Price	€11.10
52 Week High	€18.32
52 Week Low	€9.30
Beta	2.38
1 Month Change	-11.91%
3 Month Change	-7.19%
1 Year Change	-24.49%
3 Year Change	780.95%
5 Year Change	-7.03%
Change since IPO	10.12%

Recent News & Updates

May 07

Is Median Technologies (EPA:ALMDT) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

	ALMDT	FR Healthcare Services	FR Market
7D	3.9%	2.9%	-1.5%
1Y	-24.5%	-9.2%	-18.8%

Return vs Industry: ALMDT underperformed the French Healthcare Services industry which returned -12% over the past year.

Return vs Market: ALMDT underperformed the French Market which returned -5.4% over the past year.

Price Volatility

Is ALMDT's price volatile compared to industry and market?
ALMDT volatility
ALMDT Average Weekly Movement	9.3%
Healthcare Services Industry Average Movement	7.4%
Market Average Movement	6.0%
10% most volatile stocks in FR Market	10.2%
10% least volatile stocks in FR Market	3.5%

Stable Share Price: ALMDT is more volatile than 75% of French stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: ALMDT's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

Founded	Employees	CEO	Website
2002	186	Fredrik Brag	https://www.mediantechnologies.com

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies.

Median Technologies Fundamentals Summary

How do Median Technologies's earnings and revenue compare to its market cap?
ALMDT fundamental statistics
Market Cap	€171.71m
Earnings (TTM)	-€19.29m
Revenue (TTM)	€20.75m

8.3x

P/S Ratio

-8.9x

P/E Ratio

Is ALMDT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
ALMDT income statement (TTM)
Revenue	€20.75m
Cost of Revenue	€17.80m
Gross Profit	€2.95m
Other Expenses	€22.24m
Earnings	-€19.29m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	-1.25
Gross Margin	14.21%
Net Profit Margin	-92.99%
Debt/Equity Ratio	316.8%

How did ALMDT perform over the long term?

See historical performance and comparison

Valuation

Is Median Technologies undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

34.77x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ALMDT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ALMDT's fair value for valuation analysis.

Price To Earnings Ratio

PE vs Industry: ALMDT is unprofitable, so we can't compare its PE Ratio to the European Healthcare Services industry average.

PE vs Market: ALMDT is unprofitable, so we can't compare its PE Ratio to the French market.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ALMDT's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: ALMDT is overvalued based on its PB Ratio (34.8x) compared to the FR Healthcare Services industry average (2.6x).

Future Growth

How is Median Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

53.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALMDT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ALMDT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ALMDT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ALMDT's revenue (31.4% per year) is forecast to grow faster than the French market (5.8% per year).

High Growth Revenue: ALMDT's revenue (31.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ALMDT's Return on Equity is forecast to be high in 3 years time

Past Performance

How has Median Technologies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

-1.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ALMDT is currently unprofitable.

Growing Profit Margin: ALMDT is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: ALMDT is unprofitable, and losses have increased over the past 5 years at a rate of 1.8% per year.

Accelerating Growth: Unable to compare ALMDT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALMDT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-3%).

Return on Equity

High ROE: ALMDT has a negative Return on Equity (-390.68%), as it is currently unprofitable.

Financial Health

How is Median Technologies's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: ALMDT's short term assets (€47.5M) exceed its short term liabilities (€27.3M).

Long Term Liabilities: ALMDT's short term assets (€47.5M) exceed its long term liabilities (€17.2M).

Debt to Equity History and Analysis

Debt Level: ALMDT has more cash than its total debt.

Reducing Debt: ALMDT's debt to equity ratio has increased from 1.2% to 316.8% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ALMDT has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ALMDT has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 1.1% each year

Dividend

What is Median Technologies's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate ALMDT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ALMDT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ALMDT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ALMDT's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ALMDT has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.5yrs

Average management tenure

CEO

Fredrik Brag

20.33yrs

Tenure

€498,000

Compensation

Mr. Fredrik Brag founded Median Technologies S.A. in 2002 and served as its Chairman and President until April 2019 and serves as its Chief Executive Officer and General Manager. Mr. Brag has been Director...

CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Fredrik's total compensation is reasonable compared to companies of similar size in the French market.

Compensation vs Earnings: Fredrik's compensation has increased whilst the company is unprofitable.

Leadership Team

Experienced Management: ALMDT's management team is considered experienced (3.5 years average tenure).

Board Members

Experienced Board: ALMDT's board of directors are considered experienced (6.5 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.5%.

Data	Last Updated (UTC time)
Company Analysis	2022/05/23 00:00
End of Day Share Price	2022/05/23 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31